Affymetrix, Inc.

3420 Central Expressway,
Santa Clara, California 95051
United States,
(408) 731-5000
www.affymetrix.com

Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.2/yr) # 6 - - 1 - - 7
vol $598M $15M $613M
Sell (0.2/yr) # - 1 - - - - 1
  8

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest eBioscience, Inc.
$330M (2011-11-30)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Affymetrix was acquired by Thermo Fisher Scientific on January 08, 2016.

Affymetrix has acquired 7 companies of its own, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

Affymetrix’s largest acquisition to date was in 2011, when it acquired eBioscience for $330M. Affymetrix has acquired in 4 different US states. The Company’s most targeted sectors include life science (72%) and information technology (15%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 330 medical products companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Medtronic, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 7 platform acquisitions.

Join Mergr and gain access to Affymetrix’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.